BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21173017)

  • 1. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus.
    Page N; Gros F; Schall N; Décossas M; Bagnard D; Briand JP; Muller S
    Ann Rheum Dis; 2011 May; 70(5):837-43. PubMed ID: 21173017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells.
    Page N; Gros F; Schall N; Briand JP; Muller S
    Autophagy; 2011 May; 7(5):539-40. PubMed ID: 21282971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide.
    Macri C; Wang F; Tasset I; Schall N; Page N; Briand JP; Cuervo AM; Muller S
    Autophagy; 2015; 11(3):472-86. PubMed ID: 25719862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.
    Page N; Schall N; Strub JM; Quinternet M; Chaloin O; Décossas M; Cung MT; Van Dorsselaer A; Briand JP; Muller S
    PLoS One; 2009; 4(4):e5273. PubMed ID: 19390596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
    Wang F; Tasset I; Cuervo AM; Muller S
    Cells; 2020 Oct; 9(10):. PubMed ID: 33092174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P140 Peptide Leads to Clearance of Autoreactive Lymphocytes and Normalizes Immune Response in Lupus-Prone Mice.
    Schall N; Talamini L; Wilhelm M; Jouvin-Marche E; Muller S
    Front Immunol; 2022; 13():904669. PubMed ID: 35720371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151.
    Monneaux F; Parietti V; Briand JP; Muller S
    Arthritis Rheum; 2004 Oct; 50(10):3232-8. PubMed ID: 15476231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.
    Monneaux F; Lozano JM; Patarroyo ME; Briand JP; Muller S
    Eur J Immunol; 2003 Feb; 33(2):287-96. PubMed ID: 12548559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression.
    Wilhelm M; Wang F; Schall N; Kleinmann JF; Faludi M; Nashi EP; Sibilia J; Martin T; Schaeffer E; Muller S
    Arthritis Rheumatol; 2018 Jul; 70(7):1077-1088. PubMed ID: 29499102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adamantane-based dendrons for trimerization of the therapeutic P140 peptide.
    Lamanna G; Grillaud M; Macri C; Chaloin O; Muller S; Bianco A
    Biomaterials; 2014 Aug; 35(26):7553-61. PubMed ID: 24889033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus.
    Monneaux F; Parietti V; Briand JP; Muller S
    Arthritis Res Ther; 2007; 9(5):R111. PubMed ID: 17963484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH; Freed JH; Cohen PL
    J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4(+) T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein.
    Monneaux F; Briand JP; Muller S
    Eur J Immunol; 2000 Aug; 30(8):2191-200. PubMed ID: 10940910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell autoimmunity in Ig transgenic mice.
    Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
    J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
    Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II-bound self peptides from autoimmune MRL/lpr mice reveal potential T cell epitopes for autoantibody production in murine systemic lupus erythematosus.
    Freed JH; Marrs A; VanderWall J; Cohen PL; Eisenberg RA
    J Immunol; 2000 May; 164(9):4697-705. PubMed ID: 10779775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of self-peptides to treat systemic lupus erythematosus.
    Briand JP; Schall N; Muller S
    Methods Mol Biol; 2014; 1134():173-92. PubMed ID: 24497362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.